Amgen and Syapse form precision medicine alliance in oncology. Credit: Pete Linforth from Pixabay.

Amgen has partnered with Syapse to create observational research analytics for the assessment of cancer therapy outcomes.

The partners will enrol patients under the Syapse Learning Health Network to clinical trials sponsored by Amgen. The companies aim to launch these trials at community health sites.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Physicians and researchers under the Syapse Network will be able to access trial analytics, real-world evidence-based insights and collaborative research opportunities.

“Emerging software and data analytic tools are creating exciting opportunities to more rapidly develop and deliver targeted treatment options to patients.”

Amgen will also have access to trial data, which it can use to support development candidates in regulatory filings.

Syapse CEO Ken Tarkoff said: “Through this collaboration and the strategic relationships we’ve built with community health systems globally, we aim to develop evidence of clinical utility that can be used to bring molecularly targeted treatments to market more quickly and ensure more diverse groups of patients can access them.”

Amgen expects the alliance to facilitate decision-making tools. Its strategy, commercialisation and innovation senior vice-president Mike Nohaile said: “As cancer remains one of the leading causes of death around the world, emerging software and data analytic tools are creating exciting opportunities to more rapidly develop and deliver targeted treatment options to patients.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“Our collaboration with Syapse supports this effort by leveraging real-world evidence to accelerate bringing new oncology treatments to market and empowers healthcare providers with more robust insights and decision-making tools to improve patient care.”

Recently, Amgen reported financial results for the first quarter of this year. It recorded total revenues of $5.6bn, flat compared to the first quarter of last year. However, total product sales fell by 1%.